Contaminants in generic drugs may cause long-term harm to DNA: B.C. researcher
Contaminants in some generic medications used to treat heart disease, diabetes and other common conditions could damage DNA, affect basic cell functions and increase the risk of cancer, suggests a study from the University of British Columbia.
Corey Nislow, a professor in the faculty of pharmaceutical sciences, said the findings from his lab on nitrosamines, impurities that are considered probable carcinogens, suggest overseas facilities that manufacture cheaper generic drugs in high volumes require strict regulation and enforcement to ensure they're complying with standards.
Health Canada was among regulators in several countries that announced recalls in 2018 on medications containing the active ingredient Valsartan, which was found to contain a nitrosamine impurity before at least six other associated toxins were later detected in some other drugs made by different manufacturers.
Valsartan, sold under several trade names, is used to treat heart failure and high blood pressure.
While Health Canada said there is no immediate health risk associated with the use of medications containing low levels of a nitrosamine impurity, Nislow said an estimated 50 million prescriptions were written for so-called sartans in Canada alone since nitrosamines were detected in many types of generics in 2012.
It's not known if patients who took the drug for six years before the recalls could experience long-term effects, he said.
In order to better understand the impact of nitrosamines, researchers at Nislow's lab studied them in yeast, which shares about half of its genes with humans, making it a good substitute for human cells in experiments that could later lead to studies in people.
Researchers started with 4,800 strains of yeast and added high doses of nitrosamines to the entire batch. Then they deleted each gene, one at a time, to try and determine how the toxin would affect its growth.
The strains that were missing genes that repair DNA and the machinery that makes cell proteins grew five to 50 times slower, Nislow said.
A study outlining the results was published this week in the journal Scientific Reports.
“The one single take-home message is that people have been taking medicines with this contaminant for a long time and we don't know the long-term consequences,” he said. “Now that we can follow up on those genes and figure out exactly why they're needed, we could get clues as to how we can help people who have been taking those contaminants for six years without knowing it.”
Damage to DNA can cause mutations that could be inherited and if they're unrepaired by the body, could lead to cancer, Nislow said.
Health Canada said it is collaborating with six other international regulators including the U.S. Food and Drug Administration, the European Medicines Agency and Japan's Ministry of Health to better understand the global issue of nitrosamines.
The agency said it sent a letter last December to drug manufacturers to conduct detailed evaluations of their manufacturing procedures for the potential presence of nitrosamines.
It said patients should talk to their health provider before stopping a prescribed medication and that not treating a condition may pose a greater risk than the potential exposure to a nitrosamine impurity.
Most of the inspections of facilities that make so-called active pharmaceutical ingredients are based on a self-reporting system, potentially putting consumers at risk, Nislow said.
“This particular case, with this particular contaminant, we think arose when they changed their manufacturing process to a cheaper process and no one was informed. And because no one was looking for this contaminant, it went unreported and undetected for nearly a decade.”
Health Canada, the U.S. Food and Drug Administration and the European Medicines Agency are among regulators that have been testing drugs that are shipped from overseas.
However, he said that's not good enough.
“In order to effect a long-lasting change, they should be testing at the point of manufacture, which is overseas.”
Many of the drugs are made in China and India, where costs are lower, Nislow said.
“But I wonder if this is an elaborate game of Whack-A-Mole, where we're chasing after the last quality control failure.
“If we want our drug prices low and we're willing to source our materials from overseas and we want them to be safe, we have to go back to 20 years ago when the enforcement mechanisms were more consequential.”
Ultimately, consumers may need to demand better quality control for generic drugs, Nislow said.
This report by The Canadian Press was first published June 15, 2021.
CTVNews.ca Top Stories
'A beautiful soul': Funeral held for baby boy killed in wrong-way crash on Highway 401
A funeral was held on Wednesday for a three-month-old boy who died after being involved in a wrong-way crash on Highway 401 in Whitby last week.
'Sophisticated' cyberattacks detected on B.C. government networks, premier says
There has been a "sophisticated" cybersecurity breach detected on B.C. government networks, Premier David Eby confirmed Wednesday evening.
Police handcuff man trying to enter Drake's Toronto mansion
Toronto police say a man was taken into custody outside Drake's Bridle Path mansion Wednesday afternoon after he tried to gain access to the residence.
Biden says he will stop sending bombs and artillery shells to Israel if they launch major invasion of Rafah
U.S. President Joe Biden said for the first time Wednesday he would halt shipments of American weapons to Israel, which he acknowledged have been used to kill civilians in Gaza, if Prime Minister Benjamin Netanyahu orders a major invasion of the city of Rafah.
Canucks claw out 5-4 comeback win over Oilers in Game 1
Dakota Joshua had a goal and two assists and the Vancouver Canucks scored three third-period goals to claw out a 5-4 comeback victory over the Edmonton Oilers in Game 1 of their second-round playoff series Wednesday.
Nijjar murder suspect says he had Canadian study permit in immigration firm's video
One of the Indian nationals accused of murdering British Columbia Sikh activist Hardeep Singh Nijjar says in a social media video that he received a Canadian study permit with the help of an Indian immigration consultancy.
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Quebec premier defends new museum on Quebecois nation after Indigenous criticism
Quebec Premier Francois Legault is defending his comments about a new history museum after he was accused by a prominent First Nations group of trying to erase their history.
U.S. presidential candidate RFK Jr. had a brain worm, has recovered, campaign says
Independent U.S. presidential candidate Robert F. Kennedy Jr. had a parasite in his brain more than a decade ago, but has fully recovered, his campaign said, after the New York Times reported about the ailment.